# Rein Therapeutics, Inc.: Form 8-K, filed Feb 19, 2026

- Company: [Rein Therapeutics, Inc.](/companies/rntx.md) (CIK 1420565)
- Form: 8-K
- Filed: 2026-02-19
- Accepted by EDGAR: Feb 19, 2026, 16:37 ET
- Period: 2026-02-16
- Accession: 0001193125-26-059545
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1420565/000119312526059545/d31606d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1420565/000119312526059545/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1420565/000119312526059545/d31606d8k.htm

Filed Feb 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-059545. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.
